IRCCS Istituto Clinico Humanitas U.O. Medicina D'Urgenza

Milan 20089

0 studies enrolling now · 2 studies all time

What they study most

Infectious Pneumonia, Pneumonia, Viral, Severe COVID-19

Studies at this site

• Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia — Stopped early
• Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia. — Completed